Dave Gryska

Insider profile

Currently holds positions in Seagen Inc, PDL BioPharma Inc and Aerie Pharmaceuticals Inc

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Seagen Inc March 25, 2005 -
Independent Director PDL BioPharma Inc March 10, 2014 -
Independent Director Aerie Pharmaceuticals Inc Sept. 1, 2018 -
Chief Financial Officer, Executive Vice President Incyte Corp Oct. 31, 2014 - Dec. 31, 2018
Lead Independent Director Aerie Pharmaceuticals Inc Jan. 1, 2012 - May 15, 2015
Independent Director Argos Therapeutics Inc Jan. 1, 2012 - Oct. 31, 2014
Director Aerie Pharmaceuticals Inc None -

Dave Gryska's trades of Definium Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-05 2024-12-05 B Purchase
80,164 +41.8%
191.43
US$2,520,192
80,164 +41.8% 191.43 US$2,520,192
2024-08-26 2024-08-23 B Purchase
1,813 +11.1%
494.82
US$2,756,790
1,813 +11.1% 494.82 US$2,756,790
2022-11-15 2022-11-11 S Sale
76,424 -46.8%
472.93
US$2,690,861
76,424 -46.8% 472.93 US$2,690,861
2022-04-21 2022-04-19 PlS Planned sale
690 -1.5%
145.08
US$100,105
690 -1.5% 145.08 US$100,105
2022-04-21 2022-04-19 PlS Planned sale
1,516 -3.2%
144.17
US$218,562
1,516 -3.2% 144.17 US$218,562
2022-04-21 2022-04-19 PlS Planned sale
1,794 -3.7%
143.32
US$257,116
1,794 -3.7% 143.32 US$257,116
2022-02-09 2022-02-07 PlS Planned sale
2,371 -4.9%
139.42
US$330,565
2,371 -4.9% 139.42 US$330,565
2022-02-09 2022-02-07 PlS Planned sale
1,029 -2.2%
138.66
US$142,681
1,029 -2.2% 138.66 US$142,681
2022-02-09 2022-02-07 PlS Planned sale
1,100 -2.3%
137.45
US$151,195
1,100 -2.3% 137.45 US$151,195
2022-02-01 2022-01-28 PlS Planned sale
214 -0.5%
124.23
US$26,585
214 -0.5% 124.23 US$26,585
2022-02-01 2022-01-28 PlS Planned sale
883 -1.9%
123.39
US$108,953
883 -1.9% 123.39 US$108,953
2022-02-01 2022-01-28 PlS Planned sale
2,553 -5.2%
122.43
US$312,564
2,553 -5.2% 122.43 US$312,564
2022-02-01 2022-01-28 PlS Planned sale
850 -1.8%
121.69
US$103,436
850 -1.8% 121.69 US$103,436
2022-01-19 2022-01-14 PlS Planned sale
4,500 -8.9%
135.24
US$608,581
4,500 -8.9% 135.24 US$608,581
2020-12-17 2020-12-16 S Sale
75,000 -77.8%
2.68
US$201,000
75,000 -77.8% 2.68 US$201,000
2020-12-04 2020-12-03 S Sale
75,000 -71.2%
2.52
US$189,000
75,000 -71.2% 2.52 US$189,000
2020-11-24 2020-11-23 S Sale
50,000 -32.2%
2.43
US$121,500
50,000 -32.2% 2.43 US$121,500
2020-11-23 2020-11-19 S Sale
7,871 -14.9%
173.25
US$1,363,651
7,871 -14.9% 173.25 US$1,363,651
2020-11-23 2020-11-19 S Sale
7,129 -13.7%
174.20
US$1,241,872
7,129 -13.7% 174.20 US$1,241,872
2020-11-19 2020-11-18 S Sale
50,000 -34.4%
2.39
US$119,500
50,000 -34.4% 2.39 US$119,500
2020-11-19 2020-11-17 S Sale
100,000 -40.8%
2.40
US$240,000
100,000 -40.8% 2.40 US$240,000
2020-11-06 2020-11-05 S Sale
4,500 -9.1%
180.60
US$812,699
4,500 -9.1% 180.60 US$812,699
2019-10-03 2019-10-01 PlS Planned sale
2,500 -4.9%
84.85
US$212,125
2,500 -4.9% 84.85 US$212,125
2019-10-03 2019-10-01 PlS Planned sale
2,500 -4.9%
85.33
US$213,325
2,500 -4.9% 85.33 US$213,325
2019-07-19 2019-07-17 PlS Planned sale
5,000 -9.4%
75.00
US$375,000
5,000 -9.4% 75.00 US$375,000
2019-04-03 2019-04-01 PlS Planned sale
206 -0.5%
74.01
US$15,246
206 -0.5% 74.01 US$15,246
2019-04-03 2019-04-01 PlS Planned sale
4,794 -9.6%
73.38
US$351,784
4,794 -9.6% 73.38 US$351,784
2019-01-10 2019-01-08 PlS Planned sale
5,000 -10.0%
65.04
US$325,200
5,000 -10.0% 65.04 US$325,200